litlas
Log inCreate account

Mark B. Orringer

Active 1972–2020

100
Papers
25,530
Citations
86
h-index
100
i10-index

Citations

Citations per year for Mark B. Orringer1976: 4 citations1977: 1 citations1978: 2 citations1979: 6 citations1980: 2 citations1981: 6 citations1982: 3 citations1983: 5 citations1984: 9 citations1985: 10 citations1986: 18 citations1987: 18 citations1988: 15 citations1989: 19 citations1990: 17 citations1991: 22 citations1992: 26 citations1993: 46 citations1994: 43 citations1995: 60 citations1996: 58 citations1997: 54 citations1998: 64 citations1999: 83 citations2000: 94 citations2001: 92 citations2002: 75 citations2003: 156 citations2004: 204 citations2005: 200 citations2006: 172 citations2007: 162 citations2008: 187 citations2009: 262 citations2010: 262 citations2011: 263 citations2012: 250 citations2013: 223 citations2014: 230 citations2015: 168 citations2016: 177 citations2017: 143 citations2018: 131 citations2019: 558 citations2020: 510 citations2021: 419 citations2022: 269 citations2023: 157 citations2024: 238 citations2025: 82 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,653 citing papers, 32.4% of this breakdownChina: 1,156 citing papers, 14.1% of this breakdownUnited Kingdom: 422 citing papers, 5.2% of this breakdownGermany: 385 citing papers, 4.7% of this breakdownJapan: 380 citing papers, 4.6% of this breakdownCanada: 254 citing papers, 3.1% of this breakdownItaly: 240 citing papers, 2.9% of this breakdownFrance: 211 citing papers, 2.6% of this breakdownNetherlands: 210 citing papers, 2.6% of this breakdownAustralia: 201 citing papers, 2.5% of this breakdownSouth Korea: 185 citing papers, 2.3% of this breakdownSpain: 142 citing papers, 1.7% of this breakdown
0%32.4%Other 21.3%

Institutions

Fields

  • Medicine58.3%
  • Biochemistry, Genetics and Molecular Biology33.4%
  • Immunology and Microbiology1.9%
  • Chemistry1.4%
  • Computer Science1.4%
  • Neuroscience0.8%
  • Other2.8%

Topics

  • Esophageal Cancer Research and Treatment6.6%
  • Gastric Cancer Management and Outcomes4.3%
  • Esophageal and GI Pathology4.1%
  • Lung Cancer Treatments and Mutations3.3%
  • Cancer Genomics and Diagnostics2.9%
  • Gene expression and cancer classification2.7%
  • Other76.1%

Coauthors

All papers

Open in search
  1. Somatic mutations affect key pathways in lung adenocarcinoma

    Authors: Li Ding, Gad Getz, David A. Wheeler, Elaine R. Mardis, Michael D. McLellan, Kristian Cibulskis, Carrie Sougnez, Heidi Greulich, Donna M. Muzny, Margaret Morgan, Lucinda Fulton, Robert S. Fulton, Qunyuan Zhang, Michael C. Wendl, Michael S. Lawrence, David E. Larson, Ken Chen, David J. Dooling, Aniko Sabo, Alicia Hawes, Hua Shen, Shalini N. Jhangiani, Lora Lewis, Otis Hall, Yiming Zhu, Tittu Mathew, Yanru Ren, Jiqiang Yao, Steven E. Scherer, Kerstin Clerc, Ginger Metcalf, Brian Ng, Aleksandar Milosavljevic, Manuel L. Gonzalez‐Garay, John R. Osborne, Rick Meyer, Xiaoqi Shi, Yuzhu Tang, Daniel C. Koboldt, Ling Lin, Rachel M. Abbott, Tracie L. Miner, Craig Pohl, Ginger Fewell, Carrie A. Haipek, Heather K. Schmidt, Brian H. Dunford-Shore, Aldi T. Kraja, Seth D. Crosby, Christopher S. Sawyer, Tammi L. Vickery, Sacha N Sander, Jody S. Robinson, Wendy Winckler, Jennifer Baldwin, Lucian R. Chirieac, Amit Dutt, Tim Fennell, Megan Hanna, Bruce E. Johnson, Robert C. Onofrio, Roman K. Thomas, Giovanni Tonon, Barbara A. Weir, Xiao‐Jun Zhao, Liuda Ziaugra, Michael C. Zody, Thomas J. Giordano, Mark B. Orringer, Jack A. Roth, Margaret R. Spitz, Ignacio I. Wistuba, Bradley A. Ozenberger, Peter J. Good, Andrew C. Chang, David G. Beer, Mark A. Watson, Marc Ladanyi, Stephen Broderick, Akihiko Yoshizawa, William D. Travis, William Pao, Michael A. Province, George M. Weinstock, Harold Varmus, Stacey Gabriel, Eric S. Lander, Richard A. Gibbs, Matthew Meyerson, Richard K. Wilson - Nature 2008 cited by 2,750

  2. Esophageal and Esophagogastric Junction Cancers, Version 1.2015

    Authors: Jaffer A. Ajani, Thomas A. D’Amico, Khaldoun Almhanna, David J. Bentrem, Stephen Besh, Joseph Chao, Prajnan Das, Crystal S. Denlinger, Paul T. Fanta, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Steven N. Hochwald, Wayne L. Hofstetter, David H. Ilson, Dawn E. Jaroszewski, Kory Jasperson, Rajesh N. Keswani, Lawrence Kleinberg, W. Michael Korn, Stephen Leong, A. Craig Lockhart, Mary F. Mulcahy, Mark B. Orringer, James Posey, George A. Poultsides, Aaron R. Sasson, Walter J. Scott, Vivian E. Strong, Thomas K. Varghese, M. Kay Washington, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole R. McMillian, Hema Sundar - Journal of the National Comprehensive Cancer Network 2015 cited by 653

  3. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

    Authors: Jaffer A. Ajani, Thomas A. D’Amico, Khaldoun Almhanna, David J. Bentrem, Joseph Chao, Prajnan Das, Crystal S. Denlinger, Paul T. Fanta, Farhood Farjah, Charles S. Fuchs, Hans Gerdes, Michael K. Gibson, Robert E. Glasgow, James A. Hayman, Steven N. Hochwald, Wayne L. Hofstetter, David H. Ilson, Dawn E. Jaroszewski, Kimberly L. Johung, Rajesh N. Keswani, Lawrence Kleinberg, W. Michael Korn, Stephen Leong, Catherine Linn, A. Craig Lockhart, Quan P. Ly, Mary F. Mulcahy, Mark B. Orringer, Kyle A. Perry, George A. Poultsides, Walter J. Scott, Vivian E. Strong, M. Kay Washington, Benny Weksler, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole R. McMillian, Hema Sundar - Journal of the National Comprehensive Cancer Network 2016 cited by 957

  4. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers

    Authors: Vasudha Murlidhar, Rishindra M. Reddy, Shamileh Fouladdel, Lili Zhao, Martin K. Ishikawa, Svetlana Grabauskiene, Zhuo Zhang, Jules Lin, Andrew C. Chang, Philip W. Carrott, William R. Lynch, Mark B. Orringer, Chandan Kumar‐Sinha, Nallasivam Palanisamy, David G. Beer, Max S. Wicha, Nithya Ramnath, Ebrahim Azizi, Sunitha Nagrath - Cancer Research 2017 cited by 188

  5. Gene-expression profiles predict survival of patients with lung adenocarcinoma

    Authors: David G. Beer, Sharon L. R. Kardia, Chiang‐Ching Huang, Thomas J. Giordano, Albert M. Levin, David E. Misek, Lin Lin, Guoan Chen, Tarek G. Gharib, Dafydd G. Thomas, Michelle L. Lizyness, Rork Kuick, Satoru Hayasaka, Jeremy M. G. Taylor, Mark D. Iannettoni, Mark B. Orringer, Samir Hanash - Nature Medicine 2002 cited by 2,065

  6. Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer

    Authors: Feng‐Ming Kong, Randall K. Ten Haken, Matthew J. Schipper, Kirk A. Frey, James A. Hayman, Milton D. Gross, Nithya Ramnath, Khaled A. Hassan, M.M. Matuszak, Timothy A. Ritter, Nan Bi, Weili Wang, Mark B. Orringer, Kemp B. Cease, Theodore S. Lawrence, Gregory P. Kalemkerian - JAMA Oncology 2017 cited by 222

  7. Characterizing the cancer genome in lung adenocarcinoma

    Authors: Barbara A. Weir, Michele Sue‐Ann Woo, Gad Getz, Sven Perner, Li Ding, Rameen Beroukhim, William M. Lin, Michael A. Province, Aldi T. Kraja, Laura A. Johnson, Kinjal Shah, Mitsuo Sato, Roman K. Thomas, Justine A. Barletta, Ingrid B. Borecki, Stephen Broderick, Andrew C. Chang, Derek Y. Chiang, Lucian R. Chirieac, Jeonghee Cho, Yoshitaka Fujii, Adi F. Gazdar, Thomas J. Giordano, Heidi Greulich, Megan Hanna, Bruce E. Johnson, Mark G. Kris, Alex Lash, Ling Lin, Neal I. Lindeman, Elaine R. Mardis, John D. McPherson, John D. Minna, Margaret Morgan, Mark Nadel, Mark B. Orringer, John R. Osborne, Brad Ozenberger, Alex H. Ramos, James Robinson, Jack A. Roth, Valerie W. Rusch, Hidefumi Sasaki, Frances A. Shepherd, Carrie Sougnez, Margaret R. Spitz, Ming‐Sound Tsao, David Twomey, Roel G.W. Verhaak, George M. Weinstock, David A. Wheeler, Wendy Winckler, Akihiko Yoshizawa, Soyoung Yu, Maureen F. Zakowski, Qunyuan Zhang, David G. Beer, Ignacio I. Wistuba, Mark A. Watson, Levi A. Garraway, Marc Ladanyi, William D. Travis, William Pao, Mark A. Rubin, Stacey Gabriel, Richard A. Gibbs, Harold Varmus, Richard K. Wilson, Eric S. Lander, Matthew Meyerson - Nature 2007 cited by 1,125

  8. Discordant Protein and mRNA Expression in Lung Adenocarcinomas

    Authors: Guoan Chen, Tarek G. Gharib, Chiang-Ching Huang, Jeremy M. G. Taylor, David E. Misek, Sharon L. R. Kardia, Thomas J. Giordano, Mark D. Iannettoni, Mark B. Orringer, Samir Hanash, David G. Beer - Molecular & Cellular Proteomics 2002 cited by 948

  9. Gastric Cancer, Version 2.2013

    Authors: Jaffer A. Ajani, David J. Bentrem, Stephen Besh, Thomas A. D’Amico, Prajnan Das, Crystal S. Denlinger, Marwan Fakih, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Lawrence Kleinberg, W. Michael Korn, A. Craig Lockhart, Kenneth Meredith, Mary F. Mulcahy, Mark B. Orringer, James Posey, Aaron R. Sasson, Walter J. Scott, Vivian E. Strong, Thomas K. Varghese, Graham Warren, M. Kay Washington, Christopher G. Willett, Cameron D. Wright, Nicole R. McMillian, Hema Sundar - Journal of the National Comprehensive Cancer Network 2013 cited by 515

  10. Esophageal and Esophagogastric Junction Cancers

    Authors: Jaffer A. Ajani, James S. Barthel, David J. Bentrem, Thomas A. D’Amico, Prajnan Das, Crystal S. Denlinger, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Lawrence Kleinberg, W. Michael Korn, A. Craig Lockhart, Mary F. Mulcahy, Mark B. Orringer, Raymond U. Osarogiagbon, James Posey, Aaron R. Sasson, Walter J. Scott, Stephen Shibata, Vivian E. Strong, Thomas K. Varghese, Graham Warren, M. Kay Washington, Christopher G. Willett, Cameron D. Wright - Journal of the National Comprehensive Cancer Network 2011 cited by 335

  11. Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer

    Authors: Wenmei Su, Shumei Feng, Xiuyuan Chen, Xia Yang, Rui Mao, Chunfang Guo, Zhuwen Wang, Dafydd G. Thomas, Jules Lin, Rishindra M. Reddy, Mark B. Orringer, Andrew C. Chang, Zhixiong Yang, David G. Beer, Guoan Chen - Cancer Research 2018 cited by 144

  12. Evaluation of acute and chronic pain outcomes after robotic, video-assisted thoracoscopic surgery, or open anatomic pulmonary resection

    Authors: Sebastian T. Kwon, Lili Zhao, Rishindra M. Reddy, Andrew C. Chang, Mark B. Orringer, Chad M. Brummett, Jules Lin - Journal of Thoracic and Cardiovascular Surgery 2017 cited by 141

  13. Upregulated INHBA Expression May Promote Cell Proliferation and Is Associated with Poor Survival in Lung Adenocarcinoma

    Authors: Christopher W. Seder, Wibisono Hartojo, Lin Lin, Amy L. Silvers, Zhuwen Wang, Dafydd G. Thomas, Thomas J. Giordano, Guoan Chen, Andrew C. Chang, Mark B. Orringer, David G. Beer - Neoplasia 2009 cited by 182

  14. Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

    Authors: Susan G. Urba, Mark B. Orringer, Andrew T. Turrisi, Mark D. Iannettoni, Arlene A. Forastiere, Myla Strawderman - Journal of Clinical Oncology 2001 cited by 1,276

  15. Survival Outcome After Stereotactic Body Radiation Therapy and Surgery for Stage I Non-Small Cell Lung Cancer: A Meta-Analysis

    Authors: Xiangpeng Zheng, Matthew J. Schipper, Kelley M. Kidwell, Jules Lin, Rishindra M. Reddy, Yan‐Ping Ren, Andrew C. Chang, Fanzhen Lv, Mark B. Orringer, Feng‐Ming Kong - International Journal of Radiation Oncology*Biology*Physics 2014 cited by 254

  16. Distribution of distant metastases from newly diagnosed non-small cell lung cancer

    Authors: Leslie E. Quint, Srinivas Tummala, Louis J. Brisson, Isaac R. Francis, Alexander S. Krupnick, Ella A. Kazerooni, Mark D. Iannettoni, Richard I. Whyte, Mark B. Orringer - The Annals of Thoracic Surgery 1996 cited by 323

  17. INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma

    Authors: Christopher W. Seder, Wibisono Hartojo, Lin Lin, Amy L. Silvers, Zhuwen Wang, Dafydd G. Thomas, Thomas J. Giordano, Guoan Chen, Andrew C. Chang, Mark B. Orringer, David G. Beer - Journal of Thoracic Oncology 2009 cited by 96

  18. How Many Nodes Need to be Removed to Make Esophagectomy an Adequate Cancer Operation, and Does the Number Change When a Patient has Chemoradiotherapy Before Surgery?

    Authors: Jonathan Yeung, Manjit S. Bains, Arianna Barbetta, Tamar Nobel, Steven R. DeMeester, Brian E. Louie, Mark B. Orringer, Linda W. Martin, Rishindra M. Reddy, Francisco Schlottmann, Daniela Molena - Annals of Surgical Oncology 2019 cited by 37

  19. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.

    Authors: Doug Smith, Peter J. Polverini, S L Kunkel, Mark B. Orringer, Richard I. Whyte, Marie D. Burdick, Carol A. Wilke, R M Strieter - The Journal of Experimental Medicine 1994 cited by 374

  20. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.

    Authors: Guoan Chen, Tarek G. Gharib, Chiang-Ching Huang, Dafydd G. Thomas, Kerby Shedden, Jeremy M. G. Taylor, Sharon L. R. Kardia, David E. Misek, Thomas J. Giordano, Mark D. Iannettoni, Mark B. Orringer, Samir Hanash, David G. Beer - 2002 cited by 318

  21. Protein profiles associated with survival in lung adenocarcinoma

    Authors: Guoan Chen, Tarek G. Gharib, Hong Wang, Chiang‐Ching Huang, Rork Kuick, Dafydd G. Thomas, Kerby Shedden, David E. Misek, Jeremy M. G. Taylor, Thomas J. Giordano, Sharon L. R. Kardia, Mark D. Iannettoni, John Yee, Philip J. Hogg, Mark B. Orringer, Samir Hanash, David G. Beer - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 282

  22. Geographical distribution and racial disparity in esophageal cancer

    Authors: Allan Pickens, Mark B. Orringer - The Annals of Thoracic Surgery 2003 cited by 180

  23. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma

    Authors: Charles T. Miller, Lishan Lin, Anne M. Casper, Jae Young Lim, Dafydd G. Thomas, Mark B. Orringer, Andrew C. Chang, Ann F. Chambers, Thomas J. Giordano, Thomas W. Glover, David G. Beer - Oncogene 2005 cited by 160

  24. Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer

    Authors: Kyle H. Sheetz, Lili Zhao, Sven A. Holcombe, Stewart C. Wang, Rishindra M. Reddy, Jules Lin, Mark B. Orringer, Andrew C. Chang - Diseases of the Esophagus 2013 cited by 127